Head-to-head · WeighScore
MyStart Health vs TeleCareSpot
The verdict
TeleCareSpot takes it — 67.7/100 to 61.3/100.
TeleCareSpot grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleCareSpot is a telehealth weight-loss platform offering doctor-prescribed compounded GLP-1s with flat, all-inclusive monthly pricing: compounded semaglutide at $299/month and tirzepatide at $399/month (all doses), plus oral tirzepatide and phentermine.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | MyStart Health | TeleCareSpot |
|---|---|---|
| WeighScore | 61.3/100 | 67.7/100 |
| Grade | C | C |
| Scorecard rank | #328 | #177 |
| Semaglutide | $299/mo (all doses, compounded) | $299/mo (all doses, plus a separate fee, compounded) |
| Tirzepatide | $299/mo (all doses, compounded) | $399/mo |
| Coverage | Coverage not published | 48 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #328 · C
FDAWarning letter issued to Matthew Stern, CEO MyStart Health LLC. in September 2025. See the FDA warning-letter database.
Strengths
- Price Lock Guarantee — your $299 base rate doesn't rise as your dose escalates
- Fast onboarding: roughly 5-minute intake, 24-hour prescription turnaround, 2–4 day shipping
- 24/7 care team access with unlimited clinician messaging included
- LegitScript certified
- Clear Section 503A compounding disclosure on every landing page
Where it loses points
- Not BBB accredited — C+ rating with 10 complaints, mostly shipping delays and support access
- Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
- Markets oral tirzepatide, but no FDA-approved oral tirzepatide exists
- Very new company (incorporated May 2024) with a limited track record
- FDA issued Matthew Stern, CEO MyStart Health LLC. a warning letter in September 2025; the letter is public in FDA's warning-letter database
Graded #177 · C
Strengths
- Flat, all-inclusive monthly pricing with no hidden fees — compounded semaglutide $299/month and tirzepatide $399/month, all doses included
- HIPAA compliance and licensed US physicians
- Multiple options: compounded semaglutide, tirzepatide, oral tirzepatide, and phentermine
- DNA-calibrated dosing option that tailors the GLP-1 dose to how you metabolize it
- Broad coverage in 47 states and DC, with free shipping and cancel-anytime plans
Where it loses points
- The LegitScript seal ID this provider publishes, #45936855, does not resolve on LegitScript's own CDN — checked August 2026, alongside six seal IDs from other providers that returned normally in the same pass
- Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- Not available in Alaska, Mississippi, or New Jersey
- The compounding pharmacy partner is not named
- A separate weight-loss consultation fee applies (credited toward your medication package if approved)
- Trustpilot rating and review counts (4.9, 14,000+) are self-stated on the site
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 544 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.